Insulet | PODD - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Abbott USD 4.68B 439M 2026-03
Align Technology USD 109.84M 13.88M 2026-06
AtriCure USD 78.74M 8.68M 2026-06
Baxter International USD 1.03B 52M 2026-06
Becton, Dickinson and Co. USD 6.11B 173M 2026-06
Boston Scientific USD 1.23B 90M 2026-06
Cardinal Health USD 38.28B 449M 2026-06
Cooper Companies USD 233.3M 7.5M 2026-03
Dexcom USD 2.08B 134.8M 2026-06
Edwards Lifesciences USD 210.5M 29.4M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Globus Medical USD 106.94M 3.28M 2026-06
ICU Medical USD 149.16M 24.82M 2026-06
Inogen USD 21.22M 684K 2025-09
Insulet USD 123.3M 26.5M 2026-06
Integra LifeSciences USD 82.64M 5.31M 2026-06
J&J USD 9.22B 1.24B 2026-06
Medtronic USD 2.64B 75M 2026-03
Merit Medical Systems USD 70.74M 2.88M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Solventum Corp USD 701M 2M 2026-06
Stryker USD 1.59B 207M 2026-03
Tandem Diabetes Care USD 64.13M 4.27M 2026-06
Teleflex USD 143.29M 335K 2026-06
West Pharmaceutical Services USD 252.7M 400K 2026-06
Zimmer Biomet Holdings USD 352.4M 8.8M 2026-06